Table 6. Baseline covariates, genetic data and incident CAD cases on statin users and non-users in UK Biobank.
| Statin Users (n = 46,179) | Non-Statin Users (n = 96,924) | |
|---|---|---|
| Age starting statin (left) | ||
| age at recruitment (right) | 60.5± 7.9 | 54.7± 8.0 |
| Sex (=Female) | 20,921 (45.3%) | 57,682 (59.5%) |
| APOE genotype | ||
| e3e3 | 26,938 (58.3%) | 56,875 (58.7%) |
| e2e2 | 258 (0.6%) | 642 (0.7%) |
| e2e3 | 4,772 (10.3%) | 13,039 (13.5%) |
| e2e4 | 1,065 (2.3%) | 2,551 (2.6%) |
| e3e4 | 11,849 (25.7%) | 21,748 (22.4%) |
| e4e4 | 1,297 (2.8%) | 2,069 (2.1%) |
| Incident CAD (MI or angina) cases | 7,259 (15.7%) | 2,758 (2.8%) |